Avrio Biopharmaceuticals is dedicated to providing our clients with high quality, flexible and on time clinical trial material manufacturing services. Our experienced and dedicated staff and our world class facility allow us to provide our clients with timely solutions to meet the demand of early phase clinical trial material manufacturing. Our newly commissioned, cGMP manufacturing facility offers a full range of services for your clinical trial material production. Range of cGMP Support Services Pre-formulation and Formulation Development Small Molecules Biopharmaceuticals Parenteral Fill and Finish Manufacturing Lyophilization Blinding and Over-encapsulation Packaging and Labeling Regulatory Document Preparation CMC Support Clinical Supply Management Complete Clinical Trial Support Strategic Clinical Program Management Clinical Protocol Development Investigator Recruitment and Qualification Clinical Study Management, Trial Monitoring and Data Analysis Preparation of Final Regulatory Submissions
View Top Employees from Avrio BiopharmaceuticalsWebsite | http://www.avriobiopharma.com/index.php |
Revenue | $24 million |
Employees | 9 (9 on RocketReach) |
Founded | 2008 |
Address | 4 Chrysler, Irvine, California 92618, US |
Phone | (866) 695-6658 |
Fax | (949) 462-0821 |
Technologies |
HTML,
PHP,
Nginx
+2 more
(view full list)
|
Industry | Biotechnology, Pharmaceutical Manufacturing, Life Science, Biopharmaceuticals / Pharmaceutical, Pharmaceuticals, Healthcare, Science and Engineering, Pharmaceutical, Health Care |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Avrio Biopharmaceuticals employee's phone or email?
The Avrio Biopharmaceuticals annual revenue was $24 million in 2024.
9 people are employed at Avrio Biopharmaceuticals.
Avrio Biopharmaceuticals is based in Irvine, California.
The NAICS codes for Avrio Biopharmaceuticals are [3254, 32541, 325, 32].
The SIC codes for Avrio Biopharmaceuticals are [28, 283].